ArticleBiomedical optics express2026
Investigating acoustic startle priming-induced cortical network reorganization in post-stroke dysarthria: a fNIRS study.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-stroke dysarthria (PSD) involves impaired speech motor initiation and disrupted large-scale cortical coordination, but the neural effects of acoustic startle priming (ASP) during rehabilitation remain unclear. We conducted a randomized, double-blind, sham-controlled trial in 28 individuals with subacute PSD who received 2 weeks of ASP-based or sham speech training combined with conventional rehabilitation. Multimodal evaluation included Frenchay dysarthria assessment (FDA), acoustic analysis, and 53-channel functional near-infrared spectroscopy (fNIRS) during task and resting states; 26 participants were retained for final imaging analyses. After adjustment for baseline FDA scores, the ASP group showed lower post-intervention FDA scores than controls, indicating reduced dysarthria severity (F(1,24) = 7.49,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.